VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 366 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $6,386,000 | -61.5% | 62,825 | -32.4% | 0.92% | -58.4% |
| Q3 2015 | $16,575,000 | -21.7% | 92,920 | -2.5% | 2.22% | -9.9% |
| Q2 2015 | $21,169,000 | +32467.7% | 95,290 | +29220.0% | 2.47% | +35185.7% |
| Q1 2015 | $65,000 | -99.6% | 325 | -99.7% | 0.01% | -99.7% |
| Q4 2014 | $17,569,000 | +53139.4% | 122,768 | +49403.2% | 2.06% | +51450.0% |
| Q3 2014 | $33,000 | -99.3% | 248 | -99.4% | 0.00% | -99.5% |
| Q2 2014 | $5,034,000 | +27.6% | 39,918 | +33.4% | 0.82% | -8.1% |
| Q1 2014 | $3,944,000 | +20.4% | 29,918 | +7.3% | 0.89% | -15.4% |
| Q4 2013 | $3,275,000 | +146.4% | 27,895 | +119.0% | 1.06% | +45.1% |
| Q3 2013 | $1,329,000 | – | 12,736 | – | 0.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |